NECLIFE - Nectar Lifesciences

Nectar Lifesciences

NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com

Stock Price vs Company Growth

5.0%

0.8%

1.6%

12.9%

19.7%

29.7%

19.3%

10y

11.2%

all

1.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 10.6 5.0%

12.7

Company Overview

Sales

7.44 Cr

Growth: -11.8%

Profit after Tax

-280 Cr

Growth: -14.6%

Micro Cap

206 Cr

P/S: 27.7x

Industry P/S: 2.7x

Fundamentals

Sales (Cr)	₹ 7.44
Growth	-11.8%
EBITDA	N/A
P/S	27.7x
Dividend	0.0%
P/E	N/A
Book Value	₹ 1
PEG Ratio	N/A
ROE	-1337.4%
P/B	N/A

Shareholding Pattern

Institutions

Nsr Direct Pe Mauritius Llc

14.59 %

Ingain Traders, Llc

1.34 %

Iepf

0.02 %

Promoters

Sanjiv Goyal

31.33 %

Sanjiv (Huf)

24.47 %

Others

Increase Decrease No change

Company Profile Detailed

Nectar is a global pharmaceutical company specializing in Cephalosporins.

Belongs to (4 Indices)

Bse Healthcare
Bse Smallcap
BSE MidSmallCap
Bse Allcap

Investors (30)

religare...

sanjiv.g...

Followers (2)

bhaskar6

sanjayda...